[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 50
Citations 0
February 8, 2012

Differences in an Author’s Conflict of Interest Disclosures—Reply

Author Affiliations

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

JAMA. 2012;307(6):561. doi:10.1001/jama.2012.111

Editor's Note: We appreciate Dr Braunwald providing his professional and transparent explanation to clarify the differences in the reported financial disclosures among several of his recent publications in JAMA. We fully recognize that determining relevant financial relationships involves judgment and that reporting of financial disclosure information certainly is not an exact science. In fact, in one of the Commentaries1 that Dr Braunwald mentions, his co-author, Dr Gheorghiade, had reported to JAMA that he had received consulting fees from Bayer, Novartis, Sigma Tau, Johnson & Johnson, Takeda, Otsuka, and Medtronic. However, these disclosures inadvertently were omitted from the published article. The editors apologize for this oversight and regret this error. We urge all authors to fully disclose all possible conflicts of interest as recommended by the International Committee of Medical Journal Editors. A correction regarding the clarification of conflict of interest disclosures for Drs Braunwald and Gheorghiade appears in this issue.